Advertisement

Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px
Document › Details

Agilent Technologies Inc.. (2/3/26). "Press Release: Agilent Technologies and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio". Santa Clara, CA & Boston, MA.

Organisations Organisation Agilent Technologies Inc. (NYSE: A)
  Organisation 2 Virscidian LLC (formerly Inc.)
  Group Siemens (Group)
Products Product OpenLAB CDS (Chromatography Data System)
  Product 2 Analytical Studio sofware (Virscidian)
Index terms Index term Agilent–Siemens: laboratory software, 202602– collab expansion to enhance interoperability of OpenLab CDS with Virscidian Analytical Studio s/w
  Index term 2 Virscidian–Dotmatics: investment, 202409 acquisition of Virscidian by Dotmatics
Persons Person Beary, John (Agilent 202602 AVP Marketing, Productivity Solutions Division)
  Person 2 Bayliss, Mark (Siemens 202602 CTO at Virscidian)
     


Agilent Technologies, Inc. and Virscidian, LLC today announced an expanded collaboration to enhance interoperability between Agilent OpenLab CDS and Virscidian Analytical Studio. The solution enables scientists to seamlessly access chromatography data and orchestrate high-throughput workflows, including purification. It delivers greater efficiency for pharma and biopharma customers engaged in drug discovery, medicinal chemistry, and high-throughput purification processes, where operational performance is critical.

Under the collaboration, the companies are co-developing an integrated approach that will enable OpenLab CDS and Analytical Studio software to be connected via an integrated application programming interface (API) that facilitates real-time communication and streamlined data sharing between the two platforms. This new integration will create a more cohesive user experience, reducing manual intervention in experiments, and maximizing the utility of the hardware.

“We are excited to announce this strategic partnership between Agilent and Virscidian, combining our strengths to deliver enhanced value and innovative solutions that directly benefit our customers,” said John Beary, AVP Marketing, Productivity Solutions Division at Agilent.

“Scientists should be empowered with the flexibility to do their work efficiently and in a fully integrated way, especially in complex workflows like purification. By partnering with Agilent, we’re simplifying data access and workflow automation so teams can move faster with confidence. The API integration directions are about reducing difficulties today and unlocking more dynamic workflows in the future. With this collaboration, customers will have unrestricted use of their acquired data with neither Virscidian nor Agilent placing limitations on where it can be copied, used, or processed,” said Mark Bayliss, CTO at Virscidian.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.



About Virscidian

Virscidian delivers decision-driven solutions that increase productivity and accelerate outcomes across pharmaceutical, biotechnology, and agriscience R&D value chains. Virscidian’s scientific analytical desktop and enterprise software helps customers, independently of the vendor instrumentation, perform experiments such as automated reaction screening, end-to-end purification, affinity selection by mass spectrometry, compound quality control, and other high-throughput analytical techniques. Their solutions transform raw data into actionable intelligence that improves productivity and the quality of results, enabling chemists and project teams to make complex decisions from large amounts of data confidently. Their solutions are easily integrated and provide critical decisions to drive some of the most sophisticated automation platforms in the world. Virscidian was acquired by Dotmatics in 2024, which is now part of Siemens. Information about Virscidian is available at www.virscidian.com. Follow Virscidian on LinkedIn.


Media Contacts

Kate Coyle
Agilent Technologies Inc.
+1 302-633-7490
kate.coyle@agilent.com

Maggie Quale
Dotmatics
+1 831-325-7943
maggie.quale@dotmatics.com

   
Record changed: 2026-05-18

Advertisement

Picture Berlin Partner Neurotech Brain Computer Interface 650x200px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2026 Singapore 650x300px




» top